Antineoplastons are a group of naturally-occurring peptides and amino acid derivatives which control tumor growth, and have been proven in clinical studies on a number of advanced cancer cases to be highly effective and non-toxic, relative to chemotherapy.

First identified by Dr. Stanislaw Burzynski  in human blood in 1967, he observed  "[T]here were significant differences in the peptide content in the serum of cancer patients as compared with the control group."

Owing to the fact that similar peptide fractions are found in human urine and can be purified as a bulk source of antineoplastons, Dr. Burzynski began a research program "for the identification of antineoplastic peptides from urine" known as the Burzynski Research Institute (BRI), which was incorporated under the laws of the State of Delaware in 1984.[i]

The discovery that urine contains therapeutic compounds is not novel. According to Dr. Burzynski:

"Medicinal use of urine and urine extracts has been known for centuries in ancient Egypt, Greece, Rome, India and North and Central America. In modern times, the first study of growth-inhibiting substances in urine was conducted in 1937. The research on urinary peptides has a long history and was initiated by a Polish researcher, S. Bondzynski, in 1897."[ii]

Dr. Burzyinski’s research lead to the discovery of five different peptide fractions which he named Antineoplaston A1, A2, A3, A4 and A5. The first active component was identified as 3-phenylacetylamino-2,6-piperidinedione and was named Antineoplaston A10. Two synthetic derivatives of Antineoplaston A10 were named Antineoplaston AS2-1 and Antineoplaston AS2-5.

GreenMedInfo.com has done an exhaustive index of the research on the topic as found on the National Library of Medicine, which can be found below.

Latest topical blog Antineoplastons: A Cure for Cancer Ignored For 45 Years?

Member Page View Enabled

You are currently viewing this page as a full fledged member! If you would like all pages to display this detail of information and wish to sign up for a membership, please click here

User Options

Download a PDF Document of this page with up to the first 50 articlesPurchase the Exhaustive Downloadable Document on this TopicMake a Request for GMI to add more Articles on this Topic Immediately (Purchase Required)View a Printer Friendly version of this pageE-mail this page to a friendPerform a Search with this Topic
Hover over an icon for more information

Additional Topics Details for this Page

  • - 37
  • - 137

View the Evidence: Substances

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Kurume Med J. 1995 ;42(3):133-40. PMID: 7474850
Study Type : Human Study

Pubmed Data : Drugs R D. 2003 ;4(2):91-101. PMID: 12718563
Study Type : Human Study

Pubmed Data : Drugs R D. 2004 ;5(6):315-26. PMID: 15563234
Study Type : Human Study

Pubmed Data : Integr Cancer Ther. 2005 Jun ;4(2):168-77. PMID: 15911929
Study Type : Human Study

Pubmed Data : Oncol Rep. 2003 Mar-Apr;10(2):391-7. PMID: 12579278
Study Type : Human Study

Pubmed Data : Drugs Exp Clin Res. 1990 ;16(7):361-9. PMID: 2152694
Study Type : Human Study

Pubmed Data : Kurume Med J. 1995 ;42(4):241-9. PMID: 8667595
Study Type : Human Study

Pubmed Data : Integr Cancer Ther. 2006 Mar ;5(1):40-7. PMID: 16484713
Study Type : Human Study

Pubmed Data : Oncol Rep. 1997 Nov-Dec;4(6):1213-6. PMID: 21590224
Study Type : Human In Vitro

Pubmed Data : Physiol Chem Phys. 1977 ;9(6):485-500. PMID: 275868
Study Type : Human: Case Report

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:17-29. PMID: 3569012
Study Type : Human: Case Report

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:37-43. PMID: 3569014
Study Type : Human: Case Report

Pubmed Data : Oncol Rep. 1998 May-Jun;5(3):597-600. PMID: 9538158
Study Type : Human: Case Report

Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Kurume Med J. 1996 ;43(2):137-47. PMID: 8755117
Study Type : Human: Case Report, Review

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:1-11. PMID: 3569010
Study Type : Human: Case Report

Pubmed Data : Surg Today. 2003 ;33(6):448-53. PMID: 12768372
Study Type : Human: Case Report

Pubmed Data : Integr Cancer Ther. 2004 Sep ;3(3):257-61. PMID: 15312271
Study Type : Human: Case Report

Pubmed Data : Oncol Rep. 1998 Nov-Dec;5(6):1363-7. PMID: 9769368
Study Type : Human: Case Report, Review
Additional Links
Additional Keywords : advanced liver cancer

Pubmed Data : Oncol Rep. 2005 Mar ;13(3):389-95. PMID: 15706406
Study Type : Animal Study

Pubmed Data : Drugs Exp Clin Res. 1986 ;12 Suppl 1:73-5. PMID: 3743382
Study Type : Animal Study

Pubmed Data : Biomed Khim. 2005 ;51(1):48-52. PMID: 15850218
Study Type : Animal Study

Pubmed Data : Nihon Rinsho. 2003 Sep ;61 Suppl 7:505-9. PMID: 14574945
Study Type : Review

Pubmed Data : Integr Cancer Ther. 2004 Mar ;3(1):59-65. PMID: 15035877
Study Type : Commentary
Additional Links

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:61-70. PMID: 3569018
Study Type : Review
Additional Links

Pubmed Data : Drugs Exp Clin Res. 1990 ;16(7):343-9. PMID: 2092960
Study Type : Review
Additional Links

Related Blogs

Written by Sayer Ji, Founder
Could a cure for advanced, chemotherapy and radiation resistant cancer have already been discovered as far back as 1967? Could this curative substance have been so close to us for all this time, as to be part of our own blood and a constituent of our own urine?

Print Options